Search results
Found 16154 matches for
Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
Philip Burnet
Principal Investigators
BSc(Hons), MSc, PhD Philip Burnet - Associate Professor and Director of Graduate Studies
Michael Sharpe
Principal Investigators
MA (Oxon), MB BChir, MD (Cantab) Michael Sharpe - Emeritus Professor of Psychological Medicine
Philip Wilkinson
Honorary Members
BMedSci BM BS (Nottingham), FRCPsych, Dip Obst (Auckland, New Zealand), Certificate in Cognitive Therapy (Oxford), ATCL, LGSMD, CELTA Philip Wilkinson - Honorary Senior Clinical Lecturer
Beatrice Shelley
Researchers and Research Support
Beatrice Shelley - Communications and Network Coordinator
John Gallacher
Principal Investigators
PhD AFBPsS CPsychol FFPH John Gallacher - Professor of Cognitive Health; Director, Dementias Platform UK; Director, BrainWaves study of adolescent wellbeing and mental health
Bergljot Gjelsvik
Honorary Members
PhD, BA, MSt(Oxon), DClinPsy (Norwegian equivalent), Bergljot Gjelsvik - Research clinical psychologist
Denis Yukhnenko
Researchers and Research Support
MSc DPhil Denis Yukhnenko - Postdoctoral researcher
John Geddes
Principal Investigators
MD FRCPsych John Geddes - WA Handley Professor of Psychiatry; Director, NIHR Oxford Health Biomedical Research Centre
Catherine Harmer
Principal Investigators
DPhil, MA, DipLATHE Catherine Harmer - Associate Head of Department (People and Culture), Professor of Cognitive Neuroscience
Enikő Zsoldos
Honorary Members
BSc (hons) MSc (Glas) DPhil (Oxon) Enikő Zsoldos - Postdoctoral Researcher
Marieke Martens
Researchers and Research Support
BSc, MSc, DPhil Marieke Martens - NIHR Oxford Health BRC Senior Postdoctoral researcher